Form 4 for MRNA Moderna
Accepted 2024-05-30 00:00:00 ET · period of report 2024-05-28 · accession 0001127602-24-016963 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-30 | 2024-05-28 | MRNA | Hoge Stephen | Pres | M - OptEx | — | +610 | 1.47M | +0.0% | — |
| D | 2024-05-30 | 2024-05-29 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $144.50 | -341 | 1.47M | -0.0% | -$49.3K |
| D | 2024-05-30 | 2024-05-28 | MRNA | Hoge Stephen | Pres | M - OptEx | $0.00 | -610 | 6,716 | -8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-28 | M | A | 610 | — | 1,472,118 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 2 | Common | Common Stock | 2024-05-29 | S | D | 341 | $144.50 | 1,471,777 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2024-05-28 | M | D | 610 | $0.00 | 6,716 | D | — · — to — | 610 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F4) 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |